OUR MISSION
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the greatest morbidity and mortality. We are developing oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1, across multiple severe autoimmune indications, unlocking new treatment options for patients who are underserved by existing therapies. You can read more about our work here.
OUR TEAM
Ade Adeboye
Director, Clinical Development
Shauna Anderson
Associate Director, Quality
Kelly Barghausen
Director, Regulatory Affairs
Eric Bashkoff
Senior Software Engineer
Yolanda Bell
Senior Director, Supply Chain
Lisa Blackburn
Clinical Data Associate
Matt Cascino
SVP, Clinical Development
Nicholas Cozzi-Krumlauf
Clinical Research Associate
Courtney Cupples
Chief Commercial Officer
Kunle Demuren
Associate, Clinical Operations
Ben Dormitorio
Principal Biostatistician
Julianne Dragan
Senior Manager, Clinical Quality
Lisa Dyer
Associate Director, Clinical Operations
Avanti Ghanekar
Senior Director, Clinical Development
Derek Gonzalez
Clinical Research Associate
Jacob Gordon
Director, Clinical Operations
Sasha Goriounova
Manager, Clinical Development
Heather Greene
Director, Statistical Programming
Matt Griffith
Associate, Business Operations
Austin Gromatzky
SVP, Strategy & Business Development
Ruth Hager
Director, Pharmacovigilance
Dan Hazen
Controller
Daniel Herz-Roiphe
Chief Operating Officer
Whitney Holmes
Conference Planner & Executive Assistant to the CEO
Megan Huey
Head of People
Noriko Iikuni
VP, Clinical Development
Nasif Islam
Director, Strategy & Business Development
Anna Johnson
Senior Clinical Research Associate
Brendan Johnson
SVP, Early Development
Scott Jones
VP, Clinical Operations
Brian Junio
Senior Clinical Research Associate
Casandra Kigundu
Senior Manager, Regulatory Affairs
George Kokkines
General Counsel
Beth Lang
SVP, Regulatory Affairs & Pharmacovigilance
Debbie Lee
Associate Director, Accounting
Elizabeth Lewkowicz
Office Manager & Executive Assistant
Rob Livingston
SVP, CMC
Valentina Losada
Associate, Business Operations
Matt Maisak
Clinical Operations
Tyler Massaro
Director, Biostatistics
Lisa McConnachie
Associate Director, Nonclinical Development
Jenny McDaniel
Director, Data Management
Scott Mitchell
Senior Director, Analytical Development
Paul Mudd
Chief Development Officer
Martha O'Brien
Associate Director, Statistical Programming
Malhar Patel
Senior Director, Clinical Operations
Sergey Pavlenko
Director, Clinical Operations
Sabrina Pogrebivsky
Manager, Clinical Operations
Michelle Porizkova
Social Media Manager
Alissa Respet
Associate Director, Quality Systems
Lindsey Rios
SVP, Program Management & Clinical Operations
Denise Shortino
VP, Biometrics
Taryn Smith
Patient Engagement Manager
Bruce Stevens
SVP, Quality
Christin Thompson
Senior Clinical Research Associate
David Tromblay
Senior Associate, Quality
Drew Webster
Director, Clinical Operations
Flora Wong
Associate Director, Supply Chain
Frank Zhang
Senior Director, Drug Product Development & Manufacturing
Ben Zimmer
Chief Executive Officer
Ben Zimmer
Chief Executive Officer
Paul Mudd
Chief Development Officer
Courtney Cupples
Chief Commercial Officer
Daniel Herz-Roiphe
Chief Operating Officer
Austin Gromatzky
SVP, Strategy & Business Development
Frank Torti
Executive Chairman
Irena Melnikova
Director
Eric Venker
Director